Utilize este identificador para referenciar este registo: https://hdl.handle.net/1822/31883

Registo completo
Campo DCValorIdioma
dc.contributor.authorLima-Neto, Reginaldopor
dc.contributor.authorSantos, Cledirpor
dc.contributor.authorLima, Nelsonpor
dc.contributor.authorSampaio, Paulapor
dc.contributor.authorPais, Céliapor
dc.contributor.authorNeves, Rejane P.por
dc.date.accessioned2014-12-11T17:28:32Z-
dc.date.available2014-12-11T17:28:32Z-
dc.date.issued2014-
dc.identifier.issn1517-8382por
dc.identifier.urihttps://hdl.handle.net/1822/31883-
dc.description.abstractMicrobial culture collections underpin biotechnology applications and are important resources for clinical microbiology by supplying reference strains and/or performing microbial identifications as a service. Proteomic profiles by MALDI-TOF MS have been used for Candida spp. identification in clinical laboratories and demonstrated to be a fast and reliable technique for the routine identification of pathogenic yeasts. The main aim of this study was to apply MALDI-TOF MS combined with classical phenotypic and molecular approaches to identify Candida clinical isolates preserved from 1 up to 52 years in a Brazilian culture collection and assess its value for the identification of yeasts preserved in this type of collections. Forty Candida spp. clinical isolates were identified by morphological and biochemical analyses. Identifications were also performed by the new proteomic approach based on MALDI-TOF MS. Results demonstrated 15% discordance when compared with morphological and biochemical analyses. Discordant isolates were analysed by ITS sequencing, which confirmed the MALDI-TOF MS identifications and these strains were renamed in the culture collection catalogue. In conclusion, proteomic profiles by MALDI-TOF MS represents a rapid and reliable method for identifying clinical Candida species preserved in culture collections and may present clear benefits when compared with the performance of existing daily routine methods applied at health centres and hospitals.por
dc.description.sponsorshipResearch leading to these results received partial funding from the European Community's Seventh Framework Program (FP7, 2007-2013), Research Infrastructures Action, under grant agreement No. FP7-228310 (EMbaRC project). Thanks are also due to Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Brazil) for funding supportpor
dc.language.isoengpor
dc.publisherSociedade Brasileira de Microbiologia por
dc.rightsopenAccesspor
dc.subjectBRCspor
dc.subjectCandidapor
dc.subjectClinical yeastspor
dc.subjectCulture collectionspor
dc.subjectMALDI-TOF MSpor
dc.titleApplication of MALDI-TOF MS for requalification of a Candida clinical isolates culture collectionpor
dc.typearticle-
dc.peerreviewedyespor
dc.commentsCEB17933por
sdum.publicationstatuspublishedpor
oaire.citationStartPage515por
oaire.citationEndPage522por
oaire.citationIssue2por
oaire.citationConferencePlaceBrazil-
oaire.citationTitleBrazilian Journal of Microbiologypor
oaire.citationVolume45por
dc.date.updated2014-11-28T17:49:52Z-
dc.identifier.doi10.1590/S1517-83822014005000044por
dc.identifier.pmid25242936por
dc.subject.wosScience & Technologypor
sdum.journalBrazilian Journal of Microbiologypor
Aparece nas coleções:CEB - Publicações em Revistas/Séries Internacionais / Publications in International Journals/Series
DBio - Artigos/Papers

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
document_17933_1.pdf988,66 kBAdobe PDFVer/Abrir

Partilhe no FacebookPartilhe no TwitterPartilhe no DeliciousPartilhe no LinkedInPartilhe no DiggAdicionar ao Google BookmarksPartilhe no MySpacePartilhe no Orkut
Exporte no formato BibTex mendeley Exporte no formato Endnote Adicione ao seu ORCID